Clinical trial
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
NCT04036032 is registered in ClinicalTrials.gov with Connecticut Children's Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
- Lead sponsor
- Connecticut Children's Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 19, 2015
- Completion date
- August 27, 2025
- Enrollment
- 47 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, cardiotoxicity